Come up with a name for your new list and we'll add to it:
N-of-One raised a round of funding on December 16, 2013. Investors include
Converge Venture Partners.
N-of-One provides physicians with oncology treatment options through the analysis of each patient's unique molecular profile, including integrating multiple molecular tests and information from its pr…